Your browser doesn't support javascript.
loading
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Antoniotti, Carlotta; Rossini, Daniele; Pietrantonio, Filippo; Catteau, Aurélie; Salvatore, Lisa; Lonardi, Sara; Boquet, Isabelle; Tamberi, Stefano; Marmorino, Federica; Moretto, Roberto; Ambrosini, Margherita; Tamburini, Emiliano; Tortora, Giampaolo; Passardi, Alessandro; Bergamo, Francesca; Kassambara, Alboukadel; Sbarrato, Thomas; Morano, Federica; Ritorto, Giuliana; Borelli, Beatrice; Boccaccino, Alessandra; Conca, Veronica; Giordano, Mirella; Ugolini, Clara; Fieschi, Jacques; Papadopulos, Alexia; Massoué, Clémentine; Aprile, Giuseppe; Antonuzzo, Lorenzo; Gelsomino, Fabio; Martinelli, Erika; Pella, Nicoletta; Masi, Gianluca; Fontanini, Gabriella; Boni, Luca; Galon, Jérôme; Cremolini, Chiara.
Afiliação
  • Antoniotti C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Rossini D; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Catteau A; Veracyte, Marseille, France.
  • Salvatore L; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy; Oncologia Medica, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Lonardi S; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
  • Boquet I; Veracyte, Marseille, France.
  • Tamberi S; Oncology Unit, Ravenna Hospital, AUSL Romagna, Ravenna, Italy.
  • Marmorino F; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Moretto R; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.
  • Ambrosini M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.
  • Tortora G; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy; Oncologia Medica, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Passardi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy.
  • Bergamo F; Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
  • Kassambara A; Veracyte, Marseille, France.
  • Sbarrato T; Veracyte, Marseille, France.
  • Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Ritorto G; SSD ColoRectal Cancer Unit, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • Borelli B; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.
  • Boccaccino A; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Conca V; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Giordano M; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Ugolini C; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Fieschi J; Veracyte, Marseille, France.
  • Papadopulos A; Veracyte, Marseille, France.
  • Massoué C; Veracyte, Marseille, France.
  • Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
  • Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Firenze, Italy; Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
  • Gelsomino F; Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy.
  • Martinelli E; Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy.
  • Pella N; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale University Hospital, Udine, Italy.
  • Masi G; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Fontanini G; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Boni L; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Galon J; Veracyte, Marseille, France; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Paris, France; Equipe Labellisée Ligue Contre le Cancer, Paris, France.
  • Cremolini C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address: chiaracremolini@gmail.com.
Lancet Oncol ; 23(7): 876-887, 2022 07.
Article em En | MEDLINE | ID: mdl-35636444
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article